Gebelikte Kalp Hastalıkları

T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, Türkiye Anne Ölümler Raporu (2015- 2019). Bakanlık Yayın No: 1208, Ankara, 2021.

Creanga AA, Syverson C, Seed K, et al. Pregnancy- related mortality in the United States, 2011– 2013. Obstetrics & Gynecology. 2017;130:366–373. doi:10.1097/AOG.0000000000002114

Magun E, DeFilippis EM, Noble S, et al. Cardiovascular care for pregnant women with car- diovascular disease. Journal of The American College of Cardiology. 2020 76(18); 2114-2116, https://doi.org/10.1016/j.jacc.2020.08.071ABSTRACT

Clare C. Medication and the Cardiovascular System. Peate I, Hamilton C (eds.) in Fundamen- tals of Pharmacology for Midwives. John Wiley; 2022. p. 163-180.

Lang IM. What is new in the 2018 ESC guidelines for the management of cardiovascular dise- ases during pregnancy? https://doi.org/10.1007/s00508-019-1529-y

Roberts A. Mechery J, Mechery A, Clarke, B, Vause S. Management of palpitations and cardia- carrhythmias in pregnancy. Obstetrician & Gynaecologist. 2019;21(4): 263–270.

Ramlakhan KP, Johnson MR, Roos- Hesselink JW. Pregnancy and cardiovascular disease Natu- re Reviews Cardiology. 2020;17(11):718-731. doi: 10.1038/s41569-020-0390-z

Chizuko AK &Yoshimatsu J. Pharmacological treatment for cardiovascular disease during pregnancy and lactation. Journal of Cardiology. 2019;73;363–369. https://doi.org/10.1016/j. jjcc.2018.12.020

D’Souza RD, Silversides CK, Tomlinson GA, Siu SC, Assessing cardiac risk in pregnant women with heart disease: How risk scores are created and their role in clinical practice,Canadian Journal of Cardiology. 2020; 36(7);1011-1021. https://doi.org/10.1016/j.cjca.2020.02.079.

Halpern, D, Weinberg, C, Pinnelas, R. et al. Use of Medication for Cardiovascular Disease Du- ring Pregnancy: JACC State-of-the-Art Review. JACC. 2019 Feb, 73 (4) 457–476. https://doi. org/10.1016/j.jacc.2018.10.075

Davis MB, Arany Z, McNamara DM, et al. Peripartum cardiomyopathy: JACC State-of-the- Art Review. Journal of American College of Cardiology. 2020;75(2): 207-21. https://doi.or- g/10.1016/j.jacc.2019.11.014

Nanda S, Nelson-Piercy C, Mackillop L. Cardiac disease in pregnancy. Clinical Medicine.

2012;12(6), 553–560. https://doi.org/10.7861/clinmedicine.12-6-553

Tweet MS, Jennifer Lewey Nathaniel R. Smilowitzet al. Pregnancy-Associated Myocardial In- farctionPrevalence, Causes, and Interventional Management. Circulation: Cardiovascular Inter- ventions 2020;13; 292-304. DOI: 10.1161/CIRCINTERVENTIONS.120.008687

Sahu AK, Harsha MM, Rathoor S. Cardiovascular diseases in oregnancy – A brief overview. Current Cardiology Reviews 2022; 18(1): e250821195824. https://dx.doi.org/10.2174/157340 3X17666210825103653

Regitz-Zagrosek V, Seeland U, Geibel-Zehender A et al. Cardiovascular diseases in pregnancy. Deutsches Ärzteblatt international,2011;108(16): 267–73.